- Home
- Publications
- Publication Search
- Publication Details
Title
HDL: To Treat or Not To Treat?
Authors
Keywords
High-density lipoprotein, Residual cardiovascular risk, Mendelian randomization, HDL-raising drugs, HDL quality, HDL quantity
Journal
Current Atherosclerosis Reports
Volume 16, Issue 8, Pages -
Publisher
Springer Nature
Online
2014-06-02
DOI
10.1007/s11883-014-0429-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Meta-analysis: Statin Therapy Does Not Alter the Association Between Low Levels of High-Density Lipoprotein Cholesterol and Increased Cardiovascular Risk
- (2013) Haseeb Jafri et al. ANNALS OF INTERNAL MEDICINE
- High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
- (2013) Angela Pirillo et al. CARDIOLOGY
- Treating High Density Lipoprotein Cholesterol (HDL-C): Quantity Versus Quality
- (2013) Angela Pirillo et al. CURRENT PHARMACEUTICAL DESIGN
- New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs
- (2013) Giuseppe Danilo Norata et al. EUROPEAN HEART JOURNAL
- HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
- (2013) et al. EUROPEAN HEART JOURNAL
- In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption
- (2013) Sheng-Ping Wang et al. JOURNAL OF LIPID RESEARCH
- Low High-Density Lipoprotein Cholesterol Is Not a Risk Factor for Recurrent Vascular Events in Patients With Vascular Disease on Intensive Lipid-Lowering Medication
- (2013) Anton P. van de Woestijne et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients
- (2013) Subroto Acharjee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Gene silencing approaches for the management of dyslipidaemia
- (2013) Giuseppe Danilo Norata et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- MicroRNAs and lipoproteins: A connection beyond atherosclerosis?
- (2012) Giuseppe Danilo Norata et al. ATHEROSCLEROSIS
- Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial
- (2012) Thomas F. Lüscher et al. EUROPEAN HEART JOURNAL
- The Current State of Niacin in Cardiovascular Disease Prevention
- (2012) Paul M. Lavigne et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-Density Lipoprotein Cholesterol Efflux, Nitration of Apolipoprotein A-I, and Endothelial Function in Obese Women
- (2011) Edward Vazquez et al. AMERICAN JOURNAL OF CARDIOLOGY
- HDLs, immunity, and atherosclerosis
- (2011) Giuseppe D. Norata et al. CURRENT OPINION IN LIPIDOLOGY
- The surprising AIM-HIGH results are not surprising when viewed through a particle lens
- (2011) James D. Otvos Journal of Clinical Lipidology
- High-density lipoprotein cholesterol in diabetes: Is higher always better?
- (2011) Tina Costacou et al. Journal of Clinical Lipidology
- Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib
- (2011) Ronald M. Krauss et al. JOURNAL OF LIPID RESEARCH
- Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
- (2011) Zahi A Fayad et al. LANCET
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
- (2011) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib
- (2010) Laurent Yvan-Charvet et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Structure/Function Relationships of Apolipoprotein A-I Mimetic Peptides
- (2010) Wilissa D'Souza et al. CIRCULATION RESEARCH
- HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial
- (2010) Paul M Ridker et al. LANCET
- Biological, clinical and population relevance of 95 loci for blood lipids
- (2010) Tanya M. Teslovich et al. NATURE
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- High-Density Lipoprotein Cholesterol as a Risk Factor and Target of Therapy after Acute Coronary Syndrome
- (2009) Gregory G. Schwartz AMERICAN JOURNAL OF CARDIOLOGY
- Lessons Learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial
- (2009) Philip Barter AMERICAN JOURNAL OF CARDIOLOGY
- Flushing Profile of Extended-Release Niacin/Laropiprant Versus Gradually Titrated Niacin Extended-Release in Patients With Dyslipidemia With and Without Ischemic Cardiovascular Disease
- (2009) Darbie Maccubbin et al. AMERICAN JOURNAL OF CARDIOLOGY
- Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes
- (2009) Kausik K. Ray et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Dalcetrapib: no off-target toxicity on blood pressure or on genes related to the renin-angiotensin-aldosterone system in rats
- (2009) ESG Stroes et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dyslipidemia treatment of patients with diabetes mellitus in a US managed care plan: a retrospective database analysis
- (2009) Peter P Toth et al. Cardiovascular Diabetology
- Association of Circulating Cholesteryl Ester Transfer Protein Activity With Incidence of Cardiovascular Disease in the Community
- (2009) Ramachandran S. Vasan et al. CIRCULATION
- Extended-Release Niacin or Ezetimibe and Carotid Intima–Media Thickness
- (2009) Allen J. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended-Release Niacin Alters the Metabolism of Plasma Apolipoprotein (Apo) A-I and ApoB-Containing Lipoproteins
- (2008) Stefania Lamon-Fava et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone
- (2008) M J Forrest et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2008) R. Scott et al. DIABETES CARE
- CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction
- (2008) J. J. Regieli et al. EUROPEAN HEART JOURNAL
- High-Density Lipoprotein Cholesterol, High-Density Lipoprotein Particle Size, and Apolipoprotein A-I: Significance for Cardiovascular Risk
- (2008) Wim A. van der Steeg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Laropiprant on Nicotinic Acid-Induced Flushing in Patients With Dyslipidemia††A list of study investigators appears in the Appendix.
- (2007) John F. Paolini et al. AMERICAN JOURNAL OF CARDIOLOGY
- Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
- (2007) Debbie A. Lawlor et al. STATISTICS IN MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started